Table 1 Methodological summary of the studies.

From: Magnetic resonance imaging for individual prediction of treatment response in major depressive disorder: a systematic review and meta-analysis

Study + year

n

Outcome

Intervention

Duration

Modality

Analysis

Validation

Costafreda et al. 2009—1

16

Remission

CBT

16 wk

tbfMRI

SVM

LOO CV

Siegle et al. 2012

12

Response

CBT

12 wk

tbfMRI

RF

Ind. replication

Queirazza et al. 2019

37

Response

CBT

6–10 wk

tbfMRI

SVM, LR

LOO nested CV

Van Waarde et al. 2015

45

Remission

ECT

10 wk

rsfMRI

lSVM

LOO CV

Moreno-Ortega et al. 2019

19

Remission

ECT

ns

rsfMRI

LR

LOO CV

Sun et al. 2019

122

Remission + remission

ECT

3–4 wk

rsfMRI

LR

LOO CV

Redlich et al. 2016

23

Response

ECT

3–8 wk

sMRI

lSVM/GPC

LOO CV

Wade et al. 2016

34

Response

ECT

2–7 wk

sMRI

RBFSVM

LOO CV

Cao et al. 2018

24

Response + remission

ECT

3–4 wk

sMRI

lSVM

LOO CV

Jiang et al. 2018

38

Remission

ECT

3–4 wk

sMRI

LR

10-fold LOO CV+

Independent cohort rep

Wade et al. 2017

Leaver et al. 2017

44a

Remission

Response

ECT

ECT

ns

ns

sMRI

rsfMRI, aslMRI

RF

RBFSVM

Nested CV

5-fold LOO CV

Drysdale et al. 2017

124

30

Response

rTMS

4–6 wk

rsfMRI

lSVM

LOO CV

Ind. replication

Cash et al. 2019

33

Remission

rTMS

5–8 wk

rsfMRI

lSVM

LOO + k fold CV

Costafreda et al. 2009—2

Nouretdinov et al. 2011

18a

Remission

Remission

SSRI

SSRI

8 wk

8 wk

sMRI

sMRI

lSVM

TCP

LOO CV

LOO CV

Gong et al. 2011

46

Response

SSRI/TCA/SNRI

12 wk

sMRI

lSVM

LOO CV

Marquand et al. 2008

20

Response

SSRI

8 wk

tbfMRI

lSVM

LOO CV

Godlewska et al. 2018

32

Response

SSRI

6 wk

tbfMRI

LR

LOO CV

Meyer et al. 2019

22

Remission/non-response

SSRI

8 wk

tbfMRI

LR

LOO CV

Karim et al. 2018

49

Remission

SNRI

12 wk

tbfMRI

LR

10-fold LOO CV

Patel et al. 2015

19

Remission

SSRI/SNRI

ns

rsfMRI, DTI, sMRI

ADTree/lSVM/RBFSVM/L1LR

Nested LOO CV

iSPOT trials

77a

 

SSRI/SNRI

8 wk

   

Korgaonkar et al. 2014

 

Remission

  

DTI

LR

K-fold CV

Williams et al. 2015

 

Response

  

tbfMRI

LDA

LOO CV

Goldstein-Piekarski et al. 2016

 

Remission

  

tbfMRI

LR

10-fold LOO CV

Grieve et al. 2016

 

Non-remission

  

DTI

LR

Independent rep

Goldstein-Piekarski et al. 2018

 

Remission

  

rsfMRI

LR

LOO CV

  1. Reported sample sizes were not necessarily equal in articles with overlapping sample.
  2. SSRI selective serotonin reuptake inhibitor, TCA tricyclic antidepressant, SNRI serotonin-norepinephrine reuptake inhibitor, ECT electroconvulsive therapy, CBT cognitive behavioral therapy, rTMS repetitive transcranial magnetic stimulation, iTBS intermittent theta burst stimulation, AP antipsychotics, ns not specified, tb task based, rs resting state, asl arterial spin labeling, fMRI functional magnetic resonance imaging, sMRI structural magnetic resonance imaging, WB whole brain, ROI region of interest, DTI diffusion tensor imaging, lSVM linear support vector machine, RBF radial basic function, TCP transductive conformal predictor, LR logistic regression, LinR linear regression, LDA linear discriminant analysis, RF random forest, LOO CV leave-one-out cross-validation, wm white matter, sLR stepwise linear regression, beta-w beta-weights, LARS least-angle regression, PMVD proportional marginal decomposition.
  3. an is a weighted average across studies.